Neuraceq is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Life Molecular Imaging, Sa. The primary component is Florbetaben F-18.
| Product ID | 54828-001_0ba79331-febc-4573-97d0-32b7e4c3044f |
| NDC | 54828-001 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Neuraceq |
| Generic Name | Florbetaben F 18 |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2014-03-20 |
| Marketing Category | NDA / NDA |
| Application Number | NDA204677 |
| Labeler Name | Life Molecular Imaging, SA |
| Substance Name | FLORBETABEN F-18 |
| Active Ingredient Strength | 135 mCi/mL |
| Pharm Classes | Radioactive Diagnostic Agent [EPC],Positron Emitting Activity [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2014-03-20 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA204677 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2014-03-20 |
| Ingredient | Strength |
|---|---|
| FLORBETABEN F-18 | 135 mCi/mL |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() NEURACEQ 85940455 4822567 Live/Registered |
Piramal Imaging S.A. 2013-05-23 |